Data as of Nov 21
| +1.43 / +1.23%|
The 2 analysts offering 12-month price forecasts for Bio-Rad Laboratories Inc have a median target of 136.00, with a high estimate of 150.00 and a low estimate of 122.00. The median estimate represents a +15.66% increase from the last price of 117.59.
The current consensus among 2 polled investment analysts is to Buy stock in Bio-Rad Laboratories Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.